JPWO2020254658A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020254658A5
JPWO2020254658A5 JP2021575276A JP2021575276A JPWO2020254658A5 JP WO2020254658 A5 JPWO2020254658 A5 JP WO2020254658A5 JP 2021575276 A JP2021575276 A JP 2021575276A JP 2021575276 A JP2021575276 A JP 2021575276A JP WO2020254658 A5 JPWO2020254658 A5 JP WO2020254658A5
Authority
JP
Japan
Prior art keywords
antigens
autoantibodies
melanoma
patient
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021575276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537339A (ja
Publication date
Priority claimed from GBGB1908780.8A external-priority patent/GB201908780D0/en
Application filed filed Critical
Publication of JP2022537339A publication Critical patent/JP2022537339A/ja
Publication of JPWO2020254658A5 publication Critical patent/JPWO2020254658A5/ja
Pending legal-status Critical Current

Links

JP2021575276A 2019-06-19 2020-06-19 メラノーマバイオマーカー Pending JP2022537339A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1908780.8A GB201908780D0 (en) 2019-06-19 2019-06-19 Melanoma biomarkers
GB1908780.8 2019-06-19
PCT/EP2020/067245 WO2020254658A1 (en) 2019-06-19 2020-06-19 Melanoma biomarkers

Publications (2)

Publication Number Publication Date
JP2022537339A JP2022537339A (ja) 2022-08-25
JPWO2020254658A5 true JPWO2020254658A5 (enExample) 2023-09-12

Family

ID=67432302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021575276A Pending JP2022537339A (ja) 2019-06-19 2020-06-19 メラノーマバイオマーカー

Country Status (6)

Country Link
US (1) US20220317125A1 (enExample)
EP (1) EP3987289A1 (enExample)
JP (1) JP2022537339A (enExample)
CN (1) CN115176159A (enExample)
GB (1) GB201908780D0 (enExample)
WO (1) WO2020254658A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022140116A1 (en) 2020-12-21 2022-06-30 Freenome Holdings, Inc. Markers for the early detection of colon cell proliferative disorders
CN114910647A (zh) * 2022-05-07 2022-08-16 浙江大学 细丝蛋白-A-IgG抗体在制备检测血管内皮损伤试剂盒中的应用
KR102534243B1 (ko) * 2022-12-05 2023-05-31 넥스탭 주식회사 Eomes 단백질을 표적으로 하는 인터페론-γ 조절 물질의 확인방법 및 이 물질을 포함하는 의약
CN116159127B (zh) * 2023-01-17 2024-04-02 西安交通大学医学院第一附属医院 酸性核糖体蛋白p2在治疗焦虑症中的应用
CN118311257B (zh) * 2024-03-22 2025-03-28 安徽师范大学 子宫颈神经内分泌癌标志物在制备子宫颈神经内分泌癌诊断试剂中的应用
CN118604339A (zh) * 2024-05-09 2024-09-06 深圳市第二人民医院(深圳市转化医学研究院) Snrpa蛋白检测试剂在制备肝癌诊断试剂盒中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2678448A4 (en) * 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
EP2806274A1 (en) * 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
WO2019115480A1 (en) * 2017-12-12 2019-06-20 Protagen Ag Melanoma checkpoint inhibitor detection and treatment

Similar Documents

Publication Publication Date Title
JP6452718B2 (ja) 食物アレルギーを検出するためのペプチド、試薬及び方法
Rouquette et al. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods
JP5057402B2 (ja) 内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
Chandra et al. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis
CN105164535B (zh) 测定急性呼吸窘迫综合征(ards)相关生物标志物的方法、监测患者的ards的发展和治疗的方法
JP2019530875A5 (enExample)
Homburger et al. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods
JP2019535015A5 (enExample)
JP2019027952A (ja) リン酸化タウタンパク質の測定方法
Tedesco et al. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach
CN105849566B (zh) 肾脏疾病生物标志物
JP2011521216A5 (enExample)
WO2004057341A2 (en) Cvd assay
CN115176159A (zh) 黑素瘤生物标志物
Pividori et al. Electrochemical immunosensor for the diagnosis of celiac disease
Manole et al. Immunoassay techniques highlighting biomarkers in immunogenetic diseases
Koukouvinos et al. Rapid C-reactive protein determination in whole blood with a White Light Reflectance Spectroscopy label-free immunosensor for Point-of-Care applications
JPWO2020254658A5 (enExample)
US7674632B1 (en) Method and composition for homogeneous multiplexed microparticle-based assay
Chon et al. SERS-based immunoassay of anti-cyclic citrullinated peptide for early diagnosis of rheumatoid arthritis
Sauer et al. Critical role of the sample matrix in a point-of-care protein chip for sepsis
Shidara et al. Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis
WO2016188902A1 (en) A method for detecting an analyte using electromagnetic radiation
US11662347B2 (en) Method for the diagnosis of systemic lupus erythematosus (SLE)
JP4556605B2 (ja) 標的物質の測定方法および測定試薬